Mast cell stabilizing compound FPL 55618 reduces right ventricular hypertrophy and lung mast cell hyperplasia in chronically hypoxic rats
- 1 January 1981
- journal article
- research article
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 37 (1) , 75-76
- https://doi.org/10.1007/bf01965579
Abstract
Rats treated with chronic hypobaric hypoxia (21 days, 380 Torr) and mast cell stabilizing compund FPL 55618 had significantly less right ventricular hypertrophy and lung mast cell hyperplasia than rats subjected to chronic hypoxia alone. Right ventricular blood pressure was not reduced.This publication has 15 references indexed in Scilit:
- Lung Mast Cells and Hypoxic Pulmonary HypertensionPublished by S. Karger AG ,2015
- Humoral Control of the Pulmonary CirculationAnnual Review of Physiology, 1980
- H1 AND H2 HISTAMINE ACTIONS ON LUNG VESSELS; THEIR RELEVANCE TO HYPOXIC VASOCONSTRICTIONQuarterly Journal of Experimental Physiology and Cognate Medical Sciences, 1978
- Lung mast cells in rats exposed to acute hypoxia, and chronic hypoxia with recovery.Thorax, 1977
- Hypoxia and lung mast cells: influence of disodium cromoglycate.Thorax, 1976
- Factors causing and reversing vasoconstriction in unventilated lungRespiration Physiology, 1975
- Role of the Mast Cell in the Pulmonary Pressor Response to HypoxiaJournal of Clinical Investigation, 1972
- Disodium cromoglycate—Mode of action and its possible relevance to the clinical use of the drugRespiratory Medicine, 1971
- Disodium cromoglycate (Intal).1970
- Paraffin Section Thickness—A Direct Method of MeasurementStain Technology, 1944